Marlowe (LON:MRL - Free Report) had its price target reduced by Berenberg Bank from GBX 720 ($9.04) to GBX 710 ($8.92) in a research note published on Tuesday, MarketBeat Ratings reports. They currently have a buy rating on the stock.
Marlowe Stock Performance
LON MRL remained flat at GBX 490 ($6.16) during trading on Tuesday. 529,194 shares of the company's stock were exchanged, compared to its average volume of 411,474. The company has a current ratio of 1.29, a quick ratio of 0.80 and a debt-to-equity ratio of 58.34. The firm has a market capitalization of £474.22 million, a price-to-earnings ratio of -3,240.00 and a beta of 0.43. Marlowe has a one year low of GBX 310 ($3.89) and a one year high of GBX 680 ($8.54). The business's fifty day moving average is GBX 511.79 and its two-hundred day moving average is GBX 458.81.
About Marlowe
(
Get Free Report)
Marlowe plc provides compliance services and software in the United Kingdom. The company operates in two segments, Governance, Risk and Compliance; and Testing, and Inspection and Certification. It offers health and safety consultancy, risk and audit assessments, environmental, contractor management, and training services; and health and safety support services.
Further Reading
Before you consider Marlowe, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marlowe wasn't on the list.
While Marlowe currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
